Abstract:The influenza neuraminidase (NA) enzyme cleaves terminal sialic acid residues from cellular receptors, a process required for the release of newly synthesized virions. A balance of NA activity with sialic acid binding affinity of hemagglutinin (HA) is important for optimal virus replication. NA sequence evolution through genetic shift and drift contributes to the continuous modulation of influenza virus fitness and pathogenicity. A simple and reliable method for the determination of kinetic parameters of NA activity could add significant value to global influenza surveillance and provide parameters for the projection of fitness and pathogenicity of emerging virus variants. The use of fluorogenic substrate 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA) and cell- or egg-grown whole influenza virus preparations have been attractive components of NA enzyme activity investigations. We describe important criteria to be addressed when determining K(m) and V(max) kinetic parameters using this method: (1) determination of the dynamic range of MUNANA and 4-methylumbelliferone product (4-MU) fluorescence for the instrument used; (2) adjustment of reaction conditions to approximate initial rate conditions, i.e. ≤15% of substrate converted during the reaction, with signal-to-noise ratio ≥10; (3) correction for optical interference and inner filter effect caused by increasing concentrations of MUNANA substrate. The results indicate a significant interference of MUNANA with 4-MU fluorescence determination. The criteria proposed enable an improved rapid estimation of NA kinetic parameters and facilitate comparison of data between laboratories.

Methods and Current Trends in Determination of Neuraminidase Activity and Evaluation of Neuraminidase Inhibitors

Kinetic characterization of two neuraminic acid synthases and evaluation of their application potential

Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate

Sialidase Inhibitors with Different Mechanisms

Surface-Controlled Sialoside-Based Biosensing of Viral and Bacterial Neuraminidases

Mutation-induced Spatial Differences in Neuraminidase Structure and Sensitivity to Neuraminidase Inhibitors

Synthetic Sialosides Terminated with 8‐N‐Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico.

Neuraminidase from influenza virus A (H3N2): specificity towards several substrates and procedure of activity determination

A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection

Recent Advances in Anti-Influenza Agents with Neuraminidase As Target

Design, Synthesis, and Activity Study of Pyrrolidine Derivatives As Neuraminidase Inhibitors

Molecular Docking, 3d-Qsar Studies, And In Silico Adme Prediction Of P-Aminosalicylic Acid Derivatives As Neuraminidase Inhibitors

Recent advances in neuraminidase inhibitor development as anti-influenza drugs.

Impedimetric Characterization of NanA Structural Domains Activity on Sialoside-Containing Interfaces

Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors

Bioisosteres at C9 of 2,3-didehydro-5-N-acetyl neuraminic acid identify selective inhibitors of NEU3

Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors

Pharmacophore-based virtual screening, molecular docking and molecular dynamics studies for the discovery of novel neuraminidase inhibitors